DEC 04, 2019 12:55 PM PST

Predicting Death with Clinical Immune Indicators

WRITTEN BY: Kara Marker

Immune and inflammation status could help doctors predict which individuals are most at-risk for death. Results from a new study mark the first step toward linking biomarkers of health with specific diseases and therapeutic targets.

Researchers made use of data from the 1999-2010 National Health and Examination Survey (NHANES) - including more than 31,000 participants - to study the ability of immune and inflammatory clinical indicators to predict human health outcomes. Senior author Jarrod Dalton, PhD, described the study as “investigating the predictive power of components of a patient’s white blood cell count.”

White blood cell count is a clinical indicator of health and part of the normal blood work completed during a typical health exam. The study found that low levels of one type of white blood cells, called lymphocytes, is linked with death from heart disease, cancer, and respiratory infections like influenza and pneumonia. The connection between these diseases and low lymphocyte levels, or lymphopenia, held true regardless of age, other blood-based immune markers, and clinical risk factors.

Lymphocytes make up anywhere from 20 to 40 percent of all white blood cells and include B cells, T cells, and natural killer (NK) cells. Important for the immune response to infection, lymphocyte levels can be abnormally low as a result of underproduction, cellular destruction, and spleen or lymph node blockages. Conditions like AIDS are a type of lymphopenia that is acquired rather than genetic.

The link between lymphopenia and mortality grew in cases where patients also presented with other blood abnormalities. This included elevated red blood cell distribution width and C-reactive protein levels, an indicator of inflammation.

Scientists are still working to elucidate the physiological mechanisms linking these biomarkers to specific diseases. After that, scientists can develop targeted therapies.

In the meantime, explains co-author Sadeer Al-Kindi, MD, they can “design systems that allow physicians to use pragmatic immune status indicators to ensure that the 10-20% of the general population at highest risk for mortality do not fall through the cracks of routine preventive care and early detection services."

Sources: Cleveland Clinic, JAMA Network Open, National Heart, Lung, and Blood Institute

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
DEC 01, 2020
Immunology
Scar-Free Healing Starts With Mobilizing the Immune System
DEC 01, 2020
Scar-Free Healing Starts With Mobilizing the Immune System
Thanks to a new hydrogel biomaterial developed by researchers at Duke University, we are one step closer to the holy gra ...
DEC 27, 2020
Immunology
Thymus Transplantation?! It Could be Possible!
DEC 27, 2020
Thymus Transplantation?! It Could be Possible!
The thymus is an essential organ of the lymphatic system; it is responsible for developing mature T cells. T c ...
DEC 27, 2020
Microbiology
A Potential Treatment Approach for Crohn's Disease
DEC 27, 2020
A Potential Treatment Approach for Crohn's Disease
Researchers may have found a way to treat or prevent Crohn's disease, one of the most common forms of inflammatory bowel ...
FEB 01, 2021
Microbiology
A Potential Leptospirosis Vaccine is Created
FEB 01, 2021
A Potential Leptospirosis Vaccine is Created
Spirochetes are a type of free-living, spiral-shaped bacteria, some of which are harmless and others that can cause dise ...
MAR 09, 2021
Immunology
A 'Plug-and-Play' CRISPR Therapy for Flu and COVID
MAR 09, 2021
A 'Plug-and-Play' CRISPR Therapy for Flu and COVID
Researchers have developed a CRISPR treatment that could potentially treat both viruses that cause COVID-19 and influenz ...
MAR 18, 2021
Drug Discovery & Development
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
MAR 18, 2021
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
Researchers have developed a prototype for a new kind of cancer immunotherapy. The therapy uses engineered T-cells to ta ...
Loading Comments...